This website uses cookies

Some cookies are strictly necessary for the proper functioning of the website. Therefore you cannot unclick the corresponding box if you wish to visit the website. Other cookies are used for statistics and marketing purposes. We will not place them unless you agree by ticking the corresponding box. Here is a link our cookie policy

Cookies that the site cannot function properly without. This includes cookies for access to secure areas and CSRF security. Please note that Craft’s default cookies do not collect any personal or sensitive information. Craft's default cookies do not collect IP addresses. The information they store is not sent to Pixel & Tonic or any 3rd parties.
Name: CraftSessionId
Description: Craft relies on PHP sessions to maintain sessions across web requests. That is done via the PHP session cookie. Craft names that cookie “CraftSessionId” by default, but it can be renamed via the phpSessionId config setting. This cookie will expire as soon as the session expires.
Provider: this site
Expiry: Session
Name: *_identity
Description: When you log into the Control Panel, you will get an authentication cookie used to maintain your authenticated state. The cookie name is prefixed with a long, randomly generated string, followed by _identity. The cookie only stores information necessary to maintain a secure, authenticated session and will only exist for as long as the user is authenticated in Craft.
Provider: this site
Expiry: Persistent
Name: *_username
Description: If you check the "Keep me logged in" option during login, this cookie is used to remember the username for your next authentication.
Provider: this site
Expiry: Persistent
Name: CRAFT_CSRF_TOKEN
Description: Protects us and you as a user against Cross-Site Request Forgery attacks.
Provider: this site
Expiry: Session
Statistic cookies help us understand how visitors interact with websites by collecting and reporting information anonymously.
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
Details Hide Details
COOKIES
  • Home
  • The Science
  • Nu.Q® Pipeline
    • Nu.Q®
    • Nu.Q® NETs
    • Nu.Q® Vet
    • Nu.Q® Capture
    • Nu.Q® Discover
  • About Us
    • Our Values
    • Our Expert Team
    • Careers
    • Contact Us
  • Investors
  • Resources
    • News Room
    • Scientific
    • Investors
    • Veterinary Resources
  • Join Mailing List
Volition
  • Home
  • The Science
  • Nu.Q® Pipeline
    • Nu.Q®
    • Nu.Q® NETs
    • Nu.Q® Vet
    • Nu.Q® Capture
    • Nu.Q® Discover
Volition
  • About Us
    • Our Values
    • Our Expert Team
    • Careers
    • Contact Us
  • Investors
  • Resources
    • News Room
      • Press Releases
      • In Focus
      • Video Gallery
      • Media Toolkit
      • Downloads
    • Scientific
      • Clinical Papers & Posters
      • Presentations
      • Video Gallery
    • Investors
      • Presentations
      • Video Gallery
    • Veterinary Resources
  • Join Mailing List
  1. Resources
  2. ᐳ
  3. Press Room ᐳ
  4. In Focus
Press Releases In Focus Video Gallery Downloads Media Toolkit

In Focus.

Thumbnail
Mar 14, 2023

Genomeweb to Host Volition Webinar on EZH2 Inhibitors

Read more

In Focus Thumbnail
Feb 10, 2023

Celebrating International Day of Women and Girls in Science

Read more

Landscape2
Jan 24, 2023

Meet Gaetan Michel

Read more

Quote2
Jan 08, 2023

Volition Business Review 2022

Read more

Calendar2
Jan 03, 2023

What's on: January 2023

Read more

Thumbnail
Dec 21, 2022

Volition and Oncovet collaboration: interview with Dr. Jérôme Benoit

Read more

Landscape2
Nov 28, 2022

Our Scientific Advisory Board meeting 2022

Read more

Volition NE Ts infographic
Oct 10, 2022

Learn about NETs, NETosis and Nu.Q® NETs

Read more

Thumbnail 22
Oct 07, 2022

A spotlight on... Volition's Asia Strategy

Read more

Calendar3
Oct 04, 2022

October Roundup

Read more

Gael Blog
Sep 05, 2022

A spotlight on...Volition's Commercialisation Strategy

Read more

In Focus Volitions U S Clinical Product Strategy
Aug 18, 2022

A spotlight on... Volition's U.S. Clinical Product Strategy

Read more

August Calendar
Aug 01, 2022

August Roundup

Read more

Calendar landscape3
Jul 01, 2022

What's on in July

Read more

Blog Thumbnail
Jun 15, 2022

Volition to Host Second Genomeweb Webinar

Read more

DSC 0734
May 26, 2022

Volition Opens New Innovation Hub

Read more

Volition advert 1
May 04, 2022

Epigenetic cancer tests for both ends of the leash

Read more

Poster thumnail option 3
Apr 08, 2022

Volition presents at EuroMedLab 2022

Read more

Web tom
Mar 18, 2022

Meet Tom Butera

Read more

Terry Axel 2
Mar 14, 2022

Volition Hosts Genomeweb Webinar

Read more

Terry Kelly square 77552cd32f74cd3049711fb3d106cc8f 1aa1040626f53650c88312152588da0b
Feb 10, 2022

Meet Terry Kelly

Read more

1641827081334 1aa1040626f53650c88312152588da0b
Jan 11, 2022

Volition Business Review 2021

Read more

  • Contact Us
  • Downloads
  • eIFU Resources
  • Privacy Policy
  • Cookies Policy
  • Disclaimer
  • Manage Cookie Preferences
Sign up to email alerts
linkedin facebook twitter

The European Regional Development Fund and Wallonia are investing in your future

http://europe.wallonie.be

The European Regional Development Fund and Wallonia are investing in your future

http://europe.wallonie.be

MENAC - Epigenetic Modifications of Nucleosomes Associated with Cancer

Thanks to a grant of 1.990.798€ from the European Regional Development Fund and Walloon Government, we’re taking part in the MENAC project which aims to develop innovative non-invasive tests for the early detection of different types of cancer. We’re working in partnership with Synabs to create monoclonal antibodies and develop new diagnostic and theragnostic immunoassays.